Shares of Solventum Corp. SOLV advanced 1.74% to $66.63 Thursday, on what proved to be an all-around positive trading session ...

SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency ...

Healthcare solutions provider Solventum (NYSE:SOLV) announced better-than-expected revenue in Q1 CY2025, with sales up 2.7% ...

Solventum Corp. closed 22.15% below its 52-week high of $85.92, which the company reached on February 26th.

M spin-off Solventum beat analysts' estimate for first-quarter profit on Thursday, helped by higher sales of its wound care, sterilization products.

U.S. Health Secretary Robert F. Kennedy Jr. defended new surgeon general pick Casey Means on Thursday from attacks from ...

The S&P 500 Index ($SPX) (SPY) today is up +0.57%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.53%, and the Nasdaq ...

The S&P 500 Index ($SPX) (SPY) today is up +0.17%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.24%, and the Nasdaq ...

We recently published a list of Billionaire Mario Gabelli’s 10 Large-Cap Stock Picks with Huge Upside Potential. In this ...

SOLVENTUM ($SOLV) is expected to release its quarterly earnings data on Thursday, May 8th after market close, per Finnhub. Analysts are expecting revenue of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...